Oppenheimer Maintains an “Outperform Rating” on Pharmaceuticals, Inc. (IONS)
Oppenheimer Maintains an “Outperform Rating” on Pharmaceuticals, Inc. (IONS)
Oppenheimer Maintains an “Outperform Rating” on Pharmaceuticals, Inc. (IONS)
Latest in Stocks
-
Gemini surges after Winklevoss Capital Fund invests $100 million in the crypto exchange
-
-
-
How to freeze your credit (and why you should)
-
Alphabet Inc. (GOOGL): Chris Rokos Is Loading Up on This Tech Stock
-
Advisor quotes Mike Tyson after S&P 500's 9% Iran war drop: 'Everyone has a plan until they get hit in the mouth'
Summary aggregated from Yahoo Finance's public RSS feed. The full reporting belongs to Yahoo Finance — please read it on their site.